Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.65 |
| ▸ | MEN1 | O00255 | 7/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.65 |
| ▸ | HTT | P42858 | 4/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.65 |
| ▸ | NPC1 | O15118 | 4/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | XBP1 | P17861 | 1/20 | 0.65 |
| ▸ | FNTA | P49354 | 1/20 | 0.58 |
| ▸ | FNTB | P49356 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17395843 | 1.00 | MAPT (0.65) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL12443189 | 0.88 | MAPT (0.63) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL14159177 | 0.86 | MAPT (0.56) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL12443483 | 0.85 | MAPT (0.53) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL14237845 | 0.84 | MAPT (0.60) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL10182503 | 0.84 | MAPT (0.65) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL22624755 | 0.84 | MAPT (0.60) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL17395868 | 0.84 | MAPT (0.65) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL9313016 | 0.84 | CA12 (0.54) | MAPTMEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL9313011 | 0.84 | CA12 (0.54) | MAPTMEN1KMT2AHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317076-A9 | COMPOUNDS WITH ANTIMICROBIAL ACTIVITY | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2021-10-14 | — | — | US | disclosed |
| US-20200347010-A1 | COMPOUNDS WITH ANTIMICROBIAL ACTIVITY | UNIV HONG KONG POLYTECHNIC (CN) | 2020-11-05 | — | — | US | disclosed |
| US-10160828-B2 | Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2018-12-25 | — | — | US | disclosed |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2017-05-25 | — | — | US | disclosed |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2017-05-25 | — | — | US | disclosed |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2017-05-25 | — | — | US | disclosed |
| EP-3164409-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | Guang Ming Innovation Company (Wuhan) (CN) | 2017-05-10 | — | — | EP | disclosed |
| WO-2016000242-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2016-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347010-A1 | COMPOUNDS WITH ANTIMICROBIAL ACTIVITY | CFTR, FPR3, FPR1 | MAPT 4046/4885MEN1 376/4885KMT2A 4213/4885 |
| US-20210317076-A9 | COMPOUNDS WITH ANTIMICROBIAL ACTIVITY | CFTR, FPR3, FPR1 | MAPT 4046/4885MEN1 376/4885KMT2A 4213/4885 |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | F8, COASY, FADS1 | MAPT 3667/4885MEN1 289/4885KMT2A 1332/4885 |
| US-10160828-B2 | Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction | F8, COASY, FADS1 | MAPT 3667/4885MEN1 289/4885KMT2A 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.